Dopamine D1 receptor antagonism in schizophrenia: Is there reduced risk of extrapyramidal side-effects?
Jarmo Hietala, Jaakko Lappalainen, Markku Koulu, Erkka SyvälahtiVolume:
11
Year:
1990
Language:
english
DOI:
10.1016/0165-6147(90)90147-z
File:
PDF, 713 KB
english, 1990